A letter from the Federal Trade Commission said a bill in New York to ban discounts on prescriptions filled by mail order "impedes a fundamental prerequisite to consumer choice: healthy competition between retail and mail-order pharmacies, which constrains costs and maximizes access to prescription drugs."

PCMA statement: FTC to New York: Anti-Mail-Service Pharmacy Bill Would Hurt Consumers, Likely Raise Prices and Reduce Access to Prescription Drugs

Related Summaries